Initially, researchers thought that coronary vascular progenitors were derived from the cardiac mesoderm, like other cell types in the heart. These theories were first challenged by Manasek who demonstrated that the epicardium arose from extracardiac regions. 11 In recent years, several studies have demonstrated that progenitors of the epicardium and coronary vascular system were originated from PEO, which appeared to arise from splanchnic mesoderm. 12-14 At Hamburger Hamilton (HH) stage 15 in the chick, PEO is situated Vascular Medicine 2005; 10: 37-44 Abstract: Development of coronary vessels is a complex process in developmental biology and it may have clinical implications. Although coronary vessels develop as a form of vasculogenesis followed by angiogenesis, the cells of the entire coronary system do not arise from the developing heart. The key events of the coronary system formation include the generation of primordium and proepicardial organ; formation of epicardium; generation of subepicardial mesenchymal cells, and the formation, remodeling and maturation of the final vascular plexus. These events represent a complex regulation of the cell fate determination, cellular migration, epicardial/ mesenchymal transformation, and patterning of vasculatures. Recent studies suggest that several transcription factors, adhesion molecules, growth factors and signaling molecules play essential roles in these events. This article reviews the literature on the development of coronary vessels, and discusses current advances and controversies of molecular and cellular mechanisms, thereby directing future investigations.
Introduction
Defects of the coronary vascular system have significant impact on heart functions and diseases. Recent investigations indicate that embryonic coronary development is directly related to congenital coronary and cardiac anomalies and may be associated with coronary artery diseases in adulthood. 1, 2 The coronary vascular system develops early in gestation when nutrition through simple diffusion from the endocardial endothelium becomes insufficient as the myocardium thickens. Mature vessels are evident before the end of the gestation. However, during the heart development stage, the vasculogenesis and angiogenesis contributing to the maturation of coronary arteries are limited. In recent years, there have been several reviews on coronary vessel development describing the important biological events during heart development. [3] [4] [5] [6] [7] [8] [9] [10] Since advances in the field are emerging at a rapid pace, many new molecular mechanisms or controversies are reported. This article reviews the cellular events of the embryonic coronary vessel development and summarizes the most recent achievements of molecular signaling that regulates these events. The emerging controversies and future directions of research in the field are also discussed.
Cellular events of coronary vessel development
Development of coronary vessels is a complex process in embryogenesis. The majority of critical cellular events include the formation and migration of the primordium and proepicardial organ; the formation of epicardium; the generation of subepicardial space and mesenchymal cells; and the formation and remodeling of vascular plexus.
at the ventral wall of the sinus venous horn. 5, 11, [15] [16] [17] At E9.5 in the mouse or other mammalian embryos, PEO is located at the pericardial surface of the septum transversum close to the sinus venosus. 16 PEO is a transient structure that consists of a single epithelial layer covering the mesenchyme and is rich in extracellular matrix. PEO cells migrate from the dorsal body wall ventrally to spread out over the surface of the myocardium to become epicardium. 12, 17, 18 Although little is known about the initiation and regulation of the formation of PEO, the mechanical or genetic ablation of PEO results in the absence of epicardium and abnormality of the coronary vascular system. 19, 20 Formation of the epicardium At HH stage 17 in the chick and E9.5 in the mouse, PEO makes contact with the surface of the developing heart tube, and migrates on the surface of the heart. 12, 17, 18, 21 Migration of PEO to form the primitive epicardium occurs in the mouse and chicken embryos with slight differences. In chickens, PEO extends to the heart and attaches as a continuous epithelial sheet. 9, 12, 22 By contrast, murine PEO cells form cysts (vesicle-like structures), which float freely into the fluid of the pericardial cavity, and then attach to the surface of the heart forming a continuous epithelium by E10.5 to 11. 9, 23, 24 Recent studies demonstrated that the epicardium in the cardiac distal outflow tract originates from the coelomic/pericardial epithelium but not the proepicardium, which differs in its morphologic appearance, gene-expression profile, and in its ability to undergo epithelial-to-mesenchymal transformation (EMT). 25 Initial epicardium completely covers the heart at HH stage 26 (chick) and E12.5 (mouse). 3 How the PEO attaches or is directed to the specific areas of the developing heart is not known. This process may be partly controlled by spatiotemporal regulation of the expression of adhesion molecules and extracellular matrix (ECM) components on the myocardial surface. 5, 9, 10 Epicardium is essential for further coronary development. Impairment of epicardial integrity can lead to the abnormal coronary vasculature in mice that are embryonic lethal. 20, 26, 27 Subepicardial mesenchymal cells During formation of the epicardium, a space termed the subepicardial space filled with extracellular matrix appears between the epicardium and myocardium. The subepicardial matrix is a hydrated extracellular matrix, rich in proteins and growth factors that are produced by both the epicardium and the myocardium. 10 The composition of the subepicardial matrix changes while coronary vasculogenesis occurs, suggesting the involvement of subepicardial matrix in epicardial vasculogenesis. 4 The newly formed subepicardial space is soon populated with mesenchymal cells. Although the origin of the subepicardial mesenchymal cells is still under debate, they may originate from two potential sources: 7, 9 (1) epithelial cells which undergo epithelial-mesenchymal transformation (EMT); 9,13,22,28-31 and (2) mesenchymal cells which migrate from non-epicardium via free-floating proepicardial vesicles 32 or via second cardiac ligments. 17, 18, 21 Whatever the exact origin may be, fate-mapping studies have showed that the subepicardial mesenchymal cells give rise to the endothelial and smooth muscle cells (SMCs) of the coronary vessels. 7, 10, 19, 30, 33 Subepicardial matrix and subepicardial mesenchymal cells provide a biochemical environment and angioblasts, thereby playing critical roles in the coronary vessel development.
The generation of mesenchymal cells from epithelial cells is termed EMT. It is an important process during embryogenesis. Although the molecular mechanism to initiate and regulate epicardial EMT is still unclear, recent studies have suggested that FGF-1, FGF-2 and FGF-7 as well as VEGF and EGF may play a role in stimulating the epicardial EMT, while TGF-␤ may inhibit the process. 34 Several studies have demonstrated that subepicardial mesenchymal cells can invade myocardial and valvuloseptal tissues, continue to differentiate into a variety of different cell types, including coronary endothelium, coronary SMCs, interstitial fibroblasts as well as atrioventricular cushion mesenchymal cells, while other subepicardial mesenchymal cells remain in a more or less undifferentiated state. Based on these specific characteristics of the cells, some researchers have recently proposed considering subepicardial mesenchymal cells as the ultimate 'cardiac stem cells.' 7, 10, 19, 30, 33 This new evidence or discovery is inspiring and promising for embryologists who explore the potential clinical implications of these cells.
The subepicardial matrix and mesenchymal cells are not evenly distributed in the subepicardial space. The largest coronary vessels develop in the areas where considerable amounts of subepicardial matrices have accumulated and where the density of subepicardial mesenchymal cells is high. 13, 29 To date, what drives this variation of the subepicardial matrix and mesenchymal cells in the subepicardial space has not been elucidated.
Vascular plexus formation, remodeling and maturation
The epicardium of the atrioventricular sulcus is particularly thick and contains an abundance of mesenchymal cells. 5, 17 In this region, some of the subepicardial mesenchymal cells coalesce to form channels within the subepicardial space, thus becoming the endothelium of the coronary vessels by vasculogenesis. Meanwhile, some other mesenchymal cells migrate into the myocardial space and also differentiate into the endothelium of the coronary vessels. The endothelium recruit adjacent mesenchymal cells which eventually differentiate into SMCs. 3, 5, 7, 35 The primitive coronary plexus are remodeled or reshaped by angiogenesis and form the major coronary vessels. The initial phase of coronary vasculogenesis proceeds in the absence of blood flow, and the caliber of proximal and distal arteries is governed by forces other than blood flow. Subsequently, in a process involving apoptotic changes of both the aortic wall and the invading capillaries, orifices open at the level of the aortic sinuses. 36 At last, the coronary vessels connect with systemic blood circulation, providing nutrition and oxygen to the heart.
The origin of the coronary arteries to the aorta and the connection of the coronary sinus to the right atrium are in different regions of the heart. 7 It is not known how these two vessel systems run parallel on the surface of the heart but diverge to make different connections to the systemic circulation.
Although the basic morphological events that lead to the completion of the coronary circuit are well documented, the underlying molecular mechanisms of these processes are largely unknown. What draws the cells to develop blood vessels, and when and how the cell linage diversification is determined are unanswered questions and warrant further investigations.
Molecular mechanisms of coronary vascular development
As described above, coronary vessels develop as a form of vasculogenesis followed by angiogenesis. However, the early heart is devoid of angioblasts and local mesenchyme cells until the PEO delivers these progenitors to the surface of the heart. The cells must travel a long distance before they differentiate into the components of the blood vessels. This situation leads to an interesting question: 'How do cells determine when to initiate and cease migration, and to differentiate into the components of the blood vessel?' Molecular signaling and interaction occur during the entire period of the coronary vessel formation. In recent years, scientists have made great progress in understanding the molecular mechanisms of the coronary vessel development. The major achievements and molecules regulating the cellular events of the coronary vessel development are summarized in Table 1 and are discussed in detail below.
FOG-2 and GATA-4
GATA transcription factors play critical roles in the development of coronary vessels. They function through the physical interaction with other transcription factors (FOG, PU-1, Pit-1, NKX2.5, NF-AT3, and CBP/p300). 52 GATA-4 protein is present in both the endocardium and the myocardium of the developing atria and ventricles. 38 FOG-2, a cofactor for GATA-4, is expressed in the developing ventral heart tube and septum transversum at E8.5, and later expressed in the atria and all layers of ventricles, endocardium, myocardium and pericardium during embryogenesis. 37, 38, 52 The importance of FOG-2/GATA-4 in the coronary vessel development is demonstrated in the knockout mice. FOG-2 Ϫ/Ϫ embryos developed an intact epicardium but produced no epicardial-derived cells and coronary vasculature, 37 suggesting that EMT was not initiated and there was no coronary vasculature thereafter. Transgenic GATA-4 ki/ki mice impaired the physical interaction between GATA-4 and FOG-2, exhibiting features in common with FOG-2 Ϫ/Ϫ embryos. 53 These data suggest that the FOG-2/GATA-4 interaction is essential for the initiation of EMT during coronary vascular development.
VCAM-1 and ␣ ␣4 integrin
Vascular cell adhesion molecule-1 (VCAM-1) is a cytokine inducible transmembrane protein belonging to the immunoglobulin superfamily of cell adhesion molecules, and its only known ligand is ␣4␤1 integrin. 54, 55 VCAM-1 was detected in the developing myocardium from the initiation of heart development through E13.5, 20 whereas ␣4 integrin expression was observed in the PEO and epicardial cells. 23, 26 Interestingly, the phenotype of VCAM-1-deficient mice was almost the same as that observed in ␣4 integrin null embryos. 20, 26 In VCAM-1 or ␣4 integrin null embryos, the formation of the epicardium was severely inhibited and no subepicardial vessels were developed. Further examination of ␣4␤1 integrin null mice showed that PEO cells failed to bud out and attach to the heart. The few cells that were able to reach the heart failed to migrate out to form the epicardium. 23 A recent study using ␣4 integrin antisense in quail chick chimeras demonstrated that epicardial ␣4-integrin normally restrains epicardialmesenchymal transformation, invasion, and migration and is essential for correct targeting of epicardially derived mesenchyme to the developing coronary vasculature. 56 Collectively, these studies suggest that the VCAM-1/␣4 integrin-mediated adhesion in both the epicardium and the myocardium is essential for proliferation and migration of PEO cells, epicardium formation and subsequent epicardial migration.
Wilms' tumor 1
Wilms' tumor 1 (Wt1) is a zinc-finger transcription factor which is inactivated in a subset of Wilms' tumors. 27 Mutation analysis in human patients and genetic experiments in mice have revealed that Wt1 plays a role much broader than just tumor suppression. Wt1 is expressed in the PEO, migrating epicardium and, later, in the subepicardial and migrating mesenchymal cells in the myocardial wall. Upon the formation of coronary vascular SMCs, perivascular fibroblasts and intermyocardial fibroblasts, Wt1 expression is switched off. 27 In Wt1 null mice, the epicardial layer is missing over much of the cranial regions of the ventricles, atria, and aorta, and, as expected, subepicardium and its differentiated vasculogenic derivatives in myocardium are disrupted, leading to pericardial bleeding, 27 which is similar to the phenotype observed in both VCAM-1 and ␣4 integrin null mice. This observation indicates that Wt1 is also critical to the epicardium/coronary vessel development. 
Ets-1 and Ets-2
Ets-1 and Ets-2 are transcription factors for activation of several genes including other transcription factors, cell-cycle regulators, matrix-degrading proteinases, cytokeratins, cell adhesion molecules, and growth factors. 39, 57 In the developing heart, they are both expressed in the subepicardial mesenchyme and cushion mesenchyme cells. 39 After downregulation of Ets-1 and Ets-2 expression with antisense Ets retrovirus in chick embryos, the coronary vessel development was hampered. Although the epicardium covered the heart surface, it was thin with fewer subepicadial mesenchyme cells. The coronary orifices and the SMCs in the peripheral coronary arteries were missing, and the developing coronary arteries were disorganized with coronary capillaries contacting the ventricular lumen. 39 These data suggest that Ets-1 and Ets-2 play an important role in the EMT and in the migration and differentiation of mesenchymal cells in the myocardium during the coronary vessel development.
P300
P300 is a large nuclear acetyltransferase that can interact with many sequence-specific transcription factors participating in signal transduction, cellular proliferation or differentiation programs. 40 Mice harboring a single mutant allele of p300 AT-domain lead to embryonic lethality. Although the epicardium was normally formed, few subepicardial mesenchymal cells were present, and the coronary vessel network was defected. An impaired process of epithelial-mesenchymal signaling was also observed in the lung and small intestine formation during development in p300 ϩ/AS mice. 40 These data suggest that EMT during coronary vessel development is mediated by signals similar to those in other systems where p300 AT activity is essential.
FGF and VEGF
Coronary morphogenesis constitutes the proliferation and migration of angioblasts, tube formation, and further assembly of the vascular wall. Regulators of this process are multiple growth factors, including vascular endothelial growth factors (VEGF), fibroblast growth factors (FGFs), and angiopoietins and their receptors. 43, 58 During the early stage in myocardial vascularization, basic FGF (FGF-2) levels are high, 41 and VEGF expression is closely related to the sites of vascular tube formation. VEGFR2 is an early marker of epicardial and subepicardial cells committed to endothelial cell lineage. 45 Both growth factors have been found to stimulate vascular growth in the embryonic heart. 42 Further studies showed that neutralizing antibodies to either FGF-2 or VEGF inhibit capillary formation and arteriolar growth. Arteriolar diameter is also increased when anti-FGF-2 and anti-VEGF are administered in combination. 59 Thus, the hierarchical development of the arteriolar vasculature depends on both of these growth factors. However, the establishment of arterioles, as reflected by length density, is dependent on FGF-2 but not on VEGF. 43 Transgenic myocardial overexpression of FGF-1 increases coronary artery density and branching, 60 while mice lacking VEGF-B impair the recovery of coronary vessels from cardiac ischemia. 44 Erythropoietin and its receptor Erythropoietin (EPO) is known as an essential growth factor to regulate erythrocyte production in mammals by binding to its cognate receptor EPOR. 46 EPOR is expressed in the epicardium and pericardium of the developing heart from E10.5 to E14.5. In EPOR null mouse embryos, the epicardium was thin and often detached from the myocardium, and the coronary vessel network was severely affected with disorganized structures. 46 It showed that inactivation of EPO or EPOR interrupts the adhesion of the epicardium to the myocardium that is crucial to EMT, thereby inhibiting coronary vessel development.
Connexin43
Connexins are gap junction proteins, which are intercellular junctions containing membrane channels mediating the movement of ions, metabolites and secondary messengers below 1.2 kDa. 50 Many connexins are known to be involved in embryonic development. Connexin43 is expressed in PEO, epicardium and coronary SMCs. Connexin43 Ϫ/Ϫ mice induced a variety of coronary artery patterning defects and conal 'pouches'. 49 Further analysis found that inactivation of conexin43 increased the migration and proliferation rate of PEO cells, and resulted in the abnormal morphology of fibroblasts and SMCs. 49 It showed that gap junction mediated by connexin43 plays a critical role in coronary patterning formation and coronary SMC differentiation.
Other molecules
Inhibitors of rhoA-RhoK signaling blocked EMT in vitro and inhibited the formation of coronary SMCs from PEO cells in vivo. 51 Dominant-negative constructs of serum response factor (SRF) prevented the expression of coronary SMS markers, indicating a role of SRF in the coronary SMC differentiation from PEO cells. 47 Bves is a cell adhesion molecule expressed in the developing coronary vascular system, and its antibodies inhibit epicardial migration of vasculogenic cells from the proepicardium in vitro. 43, 61 Genetic overexpression of neuropilin in mice induced excess capillaries or vessels with vascular dilation. 62 Many molecules such as tenascin-X/C, capsulin, fibulin-2 and adrenomedullin/CRLR (calcitonin receptor-like receptor) are found to express in the coronary vessel system during its development; however, the functions of these molecules are still unknown. [63] [64] [65] [66] Further studies on the functions of these molecules will provide a better understanding of the molecular mechanisms of coronary vessel development.
Conclusions and perspectives
Development of the coronary vascular system is a complicated process in developmental biology. The basic road map describing the generation of coronary vessels is well documented. Generation and migration of its progenitor PEO, epicardial formation, generation of subepicardial mesenchymal cells and the final vascular plexus, and remodeling and maturation are key cellular procedures during the development of coronary vessels, and have gained the attention of many researchers. Several transcription factors, adhesion molecules, growth factors, and signaling proteins have been shown to be essential in regulating this complicated process. However, how these molecules work together tempo-spatially to regulate one or more of the cellular events remains largely unknown. It is also quite reasonable to speculate that a number of unknown molecules and signals may be involved in these complex events. Elucidation on the molecular pathways to regulate the generation and migration of PEO and epicardium, and to control the differentiation of subepicardial mesenchymal cells will not only help us to further understand normal heart vasculogenesis, but will also provide new insights into the mechanisms that underlie the etiology of congenital heart diseases and even provide potential clinical implications for heart revascularization.
